Back to Search
ROBERT PLUENNEKE, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1205808672IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
110145(MO)04-23691(KS)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Class of 1990
Research & Publications (3)
Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer.
PMID 17026805·Clin Genitourin Cancer·2006
3-trial
Phase II trial of weekly docetaxel/ gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer.
PMID 16595033·Clin Breast Cancer·2006
3-trial
Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.
PMID 14707499·Invest New Drugs·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8700 NORTH GREEN HILLS RD.
KANSAS CITY, MO 64154 - Phone
- (913) 574-2520
Quick Facts
- NPI
- 1205808672
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 36
- Publications
- 3
Are you this provider?
Claim Your Profile